Objectives Infliximab, an anti-TNF agent, is used to treat sarcoidosis that does not respond to corticosteroids or second-line agents. The efficacy of other anti-TNF agents, non-TNF biologics and ...

Landing on Mars once felt like a distant dream. Now, space agencies have sent rovers and landers to explore the Red Planet ...

Yesterday, the European Parliament voted on a report on the future of the EU biotechnology and biomanufacturing sectors.

Arabidopsis may seem like a simple plant, but at the University of Missouri, plant biochemist Jay Thelen is using it as a ...

A pioneering carbon nanodot technology, originally developed for healthcare, is now poised to transform global agriculture ...

In April of that year, patients started appearing at hospitals in the industrial city of Sverdlovsk, now known as ...

The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in ...

Professor Levin directs both the Allen Discovery Center and the Center for Regenerative and Developmental Biology at Tufts University in Massachusetts. His lab is unusual for the field of biology, a ...

According to the latest study, the demand for Global Markets for Enzymes in Industrial Applications is projected to grow from $7.9 billion ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.